Print

Interim Report of the Biohit Group 1 July to 30 September 2012  
10/25/2012 9:43:31 AM

We concluded several significant agreements during the period under review

Net sales decreased by 7.3 per cent during the first nine months. The Group’s net sales for January–September were EUR 1.4 million, while net sales for the corresponding period in the previous year amounted to EUR 1.5 million. The change in the distribution channel strategy is advancing, but replacing the distribution channel for diagnostics products lost with the subsidiaries sold to Sartorius on 14 December 2011 will take time.

//-->